NOVEL has Authored 150+ Peer Reviewed Studies in Top Journals and Conferences
News & Events
NOVEL Health Strategies Won Two Poster Award Finalist Honor at ISPOR Baltimore.
NOVEL Health Strategies Won Two Poster Award Finalist Honor at ISPOR Milan.
Biosimilars & Biobetters: Market Access Opportunities and Regulatory Challenges (Novel Health event hosted by The Pink Sheet)
Impact of Global Health Care Reforms on Pricing, Access and Health Outcomes Strategy (Podium Presentation at ISPOR Annual Meeting in Washington DC)
Blog on Burden of Rare Diseases (Hypothesis generating analyses by NOVEL Health Strategies)
Overview of Clinical, Business and Reimbursement Trends for Targeted Cancer Therapies in Nature Reviews (More Than 20,000 Downloads)
Trends In Use of Health Economic Evidence For Developing Clinical Guidelines (2015)
Patient Reported Outcomes In Glaucoma A Systematic Review (2015)
Systematic Review of Epidemiology And Burden of Pancreatic Cancer (2015)
Systematic Review of Epidemiology And Burden of Cutaneous T-Cell Lymphoma (2015)
Overview And Importance of NUB Process For Market Access of In-Patient Drugs And Devices In Germany (2015)
Impact of 2014 Essential Health Benefit Benchmark Plans On Us Managed Care (2015)
Impact of New Changes Due To Affordable Care Act On Us Market Access (2015)
Comparative Effectiveness, Approval Rates And Pricing of Drugs With FDA's Breakthrough Therapy Designations (2015)
Comparison of Ultra Orphan And Cancer Drug Pricing In The US And The UK (2015)
Systematic Review of Cost Effectiveness of Ultra-Orphan Therapies: Lesson Learned From Published HTAs And Studies (Podium Presentation, 2015)
Cost Effectiveness Trends of High Budget Impact Drugs(Podium Presentation at ISPOR Annual Meeting in Washington DC)
Note: For Full List of Our 200+ Publications or for In-Person Replay of Events Email Us at
NOVEL's Study on Oral Cancer Drugs Selected for Presentation at ASCO Annual Meeting: Relationships between food effects, patient adherence to treatment, and pharmacokinetics of oral anticancer drugs (June, 2014)
Podium & Poster Presentations at HTAi Korea
At the Health Technology Assessment HTAi Annual Meeting in Seoul, Korea, NOVEL's team was selected for podium and poster presentation.
Strategy Overview on Breakthrough Therapy Designations
NOVEL just published a comprehensive overview on all Breakthrough Therapy Designated products, covering their clinical, HEOR, and comparative effectiveness.
NOVEL Won Two Platinum and Bronze Medal Awards at AMCP
NOVEL's team won two Platinum and Bronze Medal Awards for Presentations at AMCP Nexus Educational Conference at Boston.
Annual Strategy Perspective in Nature Biotechnology
Our annual strategy series has been cited and quoted more than two hundred times. NOVLE is the only firm with long record of publishing in journals with 30+ impact factor